Association between high serum total cortisol concentrations and mortality from COVID-19
Errataetall: |
CommentIn: Lancet Diabetes Endocrinol. 2020 Oct;8(10):808. - PMID 32946816 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
The lancet. Diabetes & endocrinology - 8(2020), 8 vom: 27. Aug., Seite 659-660 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tan, Tricia [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 03.08.2020 Date Revised 22.03.2023 published: Print-Electronic CommentIn: Lancet Diabetes Endocrinol. 2020 Oct;8(10):808. - PMID 32946816 Citation Status MEDLINE |
---|
doi: |
10.1016/S2213-8587(20)30216-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311419151 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311419151 | ||
003 | DE-627 | ||
005 | 20231225142221.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/S2213-8587(20)30216-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1038.xml |
035 | |a (DE-627)NLM311419151 | ||
035 | |a (NLM)32563278 | ||
035 | |a (PII)S2213-8587(20)30216-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tan, Tricia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Association between high serum total cortisol concentrations and mortality from COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.08.2020 | ||
500 | |a Date Revised 22.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Lancet Diabetes Endocrinol. 2020 Oct;8(10):808. - PMID 32946816 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 7 | |a Hydrocortisone |2 NLM | |
650 | 7 | |a WI4X0X7BPJ |2 NLM | |
700 | 1 | |a Khoo, Bernard |e verfasserin |4 aut | |
700 | 1 | |a Mills, Edouard G |e verfasserin |4 aut | |
700 | 1 | |a Phylactou, Maria |e verfasserin |4 aut | |
700 | 1 | |a Patel, Bijal |e verfasserin |4 aut | |
700 | 1 | |a Eng, Pei C |e verfasserin |4 aut | |
700 | 1 | |a Thurston, Layla |e verfasserin |4 aut | |
700 | 1 | |a Muzi, Beatrice |e verfasserin |4 aut | |
700 | 1 | |a Meeran, Karim |e verfasserin |4 aut | |
700 | 1 | |a Prevost, A Toby |e verfasserin |4 aut | |
700 | 1 | |a Comninos, Alexander N |e verfasserin |4 aut | |
700 | 1 | |a Abbara, Ali |e verfasserin |4 aut | |
700 | 1 | |a Dhillo, Waljit S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The lancet. Diabetes & endocrinology |d 2013 |g 8(2020), 8 vom: 27. Aug., Seite 659-660 |w (DE-627)NLM233773398 |x 2213-8595 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2020 |g number:8 |g day:27 |g month:08 |g pages:659-660 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/S2213-8587(20)30216-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2020 |e 8 |b 27 |c 08 |h 659-660 |